Skip to main content
. 2014 Oct;21(10):1437–1442. doi: 10.1128/CVI.00501-14

FIG 3.

FIG 3

(A) S. Typhimurium LPS-specific IgG in samples from healthy and HIV-positive individuals (mean ± SD). *, P < 0.005. (B) Endpoint titers were determined in a subset of the samples in panel A (mean ± SD). *, P = 0.048.